An open-label safety study of first-line bevacizumab in combination with standard chemotherapy in Chinese patients with metastatic colorectal cancer treated in an expanded access program in Taiwan

Kuan Der Lee, Hong Hwa Chen, Hwei Ming Wang, Chao Jung Tsao, Tzu Chi Hsu, Chang Fang Chiu, Wu Chou Su, Jeng Yi Wang

Research output: Contribution to journalArticlepeer-review

2 Citations (Scopus)

Fingerprint Dive into the research topics of 'An open-label safety study of first-line bevacizumab in combination with standard chemotherapy in Chinese patients with metastatic colorectal cancer treated in an expanded access program in Taiwan'. Together they form a unique fingerprint.

Medicine & Life Sciences